$CLOW
Cloudweb, Inc.

2022 Q4 Form 10-Q Financial Statement

#000164033422002300 Filed on October 31, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.900K $9.150K $7.560K
YoY Change -99.99% 21.03% -99.93%
% of Gross Profit
Research & Development $18.50K $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $27.40K $9.150K $7.560K
YoY Change -99.97% 21.03% -99.94%
Operating Profit -$9.142K -$9.933K
YoY Change -7.96%
Interest Expense -$9.140K $9.142K $9.933K
YoY Change -94.49% -7.96% -39.31%
% of Operating Profit
Other Income/Expense, Net -$9.142K
YoY Change
Pretax Income -$36.54K -$18.29K -$17.49K
YoY Change -99.97% 4.57% -99.85%
Income Tax
% Of Pretax Income
Net Earnings -$36.54K -$18.29K -$17.49K
YoY Change -99.97% 4.57% -99.85%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$617.20 -$55.40K
COMMON SHARES
Basic Shares Outstanding 27.82M shares 27.82M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.66K $56.61K $56.84K
YoY Change 6.33% -0.4%
Accrued Expenses $91.59K $87.94K $135.3K
YoY Change -36.65% -34.98%
Deferred Revenue
YoY Change
Short-Term Debt $96.76K $72.41K $0.00
YoY Change
Long-Term Debt Due $155.6K $155.6K $156.4K
YoY Change -0.84% -0.46%
Total Short-Term Liabilities $493.1K $456.6K $376.9K
YoY Change 25.6% 21.13%
LONG-TERM LIABILITIES
Long-Term Debt $67.33K $67.33K $67.33K
YoY Change 0.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $67.33K $67.33K $67.33K
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $493.1K $456.6K $376.9K
Total Long-Term Liabilities $67.33K $67.33K $67.33K
Total Liabilities $560.4K $523.9K $444.3K
YoY Change 21.85% 17.93%
SHAREHOLDERS EQUITY
Retained Earnings -$233.3M -$233.3M -$128.8M
YoY Change 0.04% 81.13%
Common Stock $237.9M $237.9M $128.4M
YoY Change 85.26% 85.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$560.4K -$523.9K -$444.3K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$36.54K -$18.29K -$17.49K
YoY Change -99.97% 4.57% -99.85%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$24.35K -$12.15K -$4.380K
YoY Change 275.77% 177.4% -40.08%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.35K 12.15K 4.380K
YoY Change 275.77% 177.4% -40.08%
NET CHANGE
Cash From Operating Activities -24.35K -12.15K -4.380K
Cash From Investing Activities 0.000
Cash From Financing Activities 24.35K 12.15K 4.380K
Net Change In Cash 0.000 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$24.35K -$12.15K -$4.380K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001619227
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1184 usd
CY2022Q3 clow Original Discount
OriginalDiscount
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-199193
dei Entity Registrant Name
EntityRegistrantName
Cloudweb, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0978297
dei Entity Address Address Line1
EntityAddressAddressLine1
800 W El Camino Real Suite 180
dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94040
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
963-7749
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27819385 shares
CY2022Q3 clow Accrued Interest
AccruedInterest
171917 usd
CY2021Q4 clow Accrued Interest
AccruedInterest
144593 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-523901 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-459946 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
319385 shares
CY2022Q3 clow Stock Payable
StockPayable
0 usd
CY2021Q4 clow Stock Payable
StockPayable
104250000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-233273988 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-233207533 usd
CY2022Q3 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
-96216 usd
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
-96216 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
9150 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
7560 usd
us-gaap Professional Fees
ProfessionalFees
37950 usd
us-gaap Professional Fees
ProfessionalFees
29910 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9150 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
7560 usd
us-gaap Operating Expenses
OperatingExpenses
37950 usd
us-gaap Operating Expenses
OperatingExpenses
29910 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
9142 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
9933 usd
us-gaap Interest Expense
InterestExpense
28505 usd
us-gaap Interest Expense
InterestExpense
29495 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9142 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9933 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28505 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
29495 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-18292 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17493 usd
us-gaap Net Income Loss
NetIncomeLoss
-66455 usd
us-gaap Net Income Loss
NetIncomeLoss
-59405 usd
CY2022Q3 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2021Q3 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.06
clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.19
CY2022Q3 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
29632572 shares
CY2021Q3 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
315703 shares
clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
25291811 shares
clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
315703 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-459946 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2022Q1 clow Net Income Loss1
NetIncomeLoss1
-29028 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-488974 usd
CY2022Q2 clow Share Issuance For Repayment Of Convertible Note Amount
ShareIssuanceForRepaymentOfConvertibleNoteAmount
2500 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19135 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-505609 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-384858 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26780 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-15132 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-426770 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17493 usd
us-gaap Profit Loss
ProfitLoss
66455 usd
us-gaap Profit Loss
ProfitLoss
59405 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1184 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1800 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
497 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1430 usd
clow Increase Decrease Accrued Interest
IncreaseDecreaseAccruedInterest
27324 usd
clow Increase Decrease Accrued Interest
IncreaseDecreaseAccruedInterest
27695 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37450 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28480 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
37450 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
28480 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37450 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28480 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
104250000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
clow Debt Conversion Converted Instrument Shares Issued Amount
DebtConversionConvertedInstrumentSharesIssuedAmount
2500 usd
clow Debt Conversion Converted Instrument Shares Issued Amount
DebtConversionConvertedInstrumentSharesIssuedAmount
0 usd
clow Net Note Discount
NetNoteDiscount
0 usd
clow Net Note Discount
NetNoteDiscount
1184 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
87944 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
83972 usd
CY2021 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
67672 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76921 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55327097 shares
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
57827097 shares
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
37450 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
28480 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
72410 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
34960 usd
clow Total Promissory Notes Payable
TotalPromissoryNotesPayable
69486 usd
CY2021 clow Total Promissory Notes Payable
TotalPromissoryNotesPayable
69486 usd
clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 usd
CY2021 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 usd
clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 usd
CY2021 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 usd
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
154798 usd
CY2022Q3 clow Less Debt Discount
LessDebtDiscount
0 usd
CY2021Q4 clow Less Debt Discount
LessDebtDiscount
-1184 usd
CY2022Q3 clow Total Current Portion Of Convertible Note Payable
TotalCurrentPortionOfConvertibleNotePayable
153482 usd
CY2021Q4 clow Total Current Portion Of Convertible Note Payable
TotalCurrentPortionOfConvertibleNotePayable
154798 usd
CY2022Q3 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-153482 usd
CY2021Q4 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-154798 usd
CY2022Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q3 clow Convertible Note1
ConvertibleNote1
3574 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1184 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1800 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
153482 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 clow Common Stock
CommonStock
25000000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
104250000 usd
CY2022Q3 clow Convertible Note
ConvertibleNote
2500 usd
CY2022Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.10
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
319385 shares

Files In Submission

Name View Source Status
0001640334-22-002300-index-headers.html Edgar Link pending
0001640334-22-002300-index.html Edgar Link pending
0001640334-22-002300.txt Edgar Link pending
0001640334-22-002300-xbrl.zip Edgar Link pending
clow-20220930.xsd Edgar Link pending
clow_10q.htm Edgar Link pending
clow_ex311.htm Edgar Link pending
clow_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
clow-20220930_cal.xml Edgar Link unprocessable
clow-20220930_def.xml Edgar Link unprocessable
clow-20220930_pre.xml Edgar Link unprocessable
clow-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clow_10q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending